Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerstin Rhiem

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Breast Care (Basel, Switzerland)|March 12, 2015
Impact of Prophylactic Mastectomy in BRCA1/2 Mutation CarriersKerstin Rhiem, Rita Schmutzler
Breast Care (Basel, Switzerland)|May 12, 2015
Familial breast cancer - targeted therapy in secondary and tertiary preventionKarin Kast, Kerstin Rhiem
Current Oncology (Toronto, Ont.)|May 15, 2023
Assessing Psychological Morbidity in Cancer-Unaffected <i>BRCA1/2</i> Pathogenic Variant Carriers: A Systematic ReviewAnna Isselhard, Zoë Lautz, Kerstin Rhiem, et al.
Qualitative Research in Medicine & Healthcare|July 13, 2023
The ticking time-bomb. Health literacy in the context of genetic risk prediction in familial breast-ovarian cancer; A qualitative studyMariya Lorke, Laura Harzheim, Kerstin Rhiem, et al.
Deutsches Arzteblatt International|June 4, 2011
Hereditary breast and ovarian cancer: new genes, new treatments, new conceptsAlfons Meindl, Nina Ditsch, Karin Kast, et al.
Molecular and Clinical Oncology|August 11, 2022
Long-term survival of a <i>BRCA2</i> mutation carrier following second ovarian cancer relapse using PARPi therapy: A case reportKathrin Bredow, Britta Blümcke, Stephanie Schneider, et al.
Anticancer Research|October 15, 2010
Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomasKerstin Rhiem, Unda Todt, Barbara Wappenschmidt, et al.
Breast Care (Basel, Switzerland)|June 15, 2017
Germline Mutations in Triple-Negative Breast CancerEric Hahnen, Jan Hauke, Christoph Engel, et al.
Archives of Gynecology and Obstetrics|September 19, 2013
Supplemental screening ultrasound increases cancer detection yield in BRCA1 and BRCA2 mutation carriersKristin Bosse, Monika Graeser, Axel Goßmann, et al.
International Journal of Environmental Research and Public Health|March 25, 2022
"You Always Have It in the Back of Your Mind"-Feelings, Coping, and Support Needs of Women with Pathogenic Variants in Moderate-Risk Genes for Hereditary Breast Cancer Attending Genetic Counseling in Germany: A Qualitative Interview StudyClaudia Stracke, Clarissa Lemmen, Kerstin Rhiem, et al.
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Breast Care (Basel, Switzerland)|March 12, 2015
Impact of Prophylactic Mastectomy in BRCA1/2 Mutation CarriersKerstin Rhiem, Rita Schmutzler
Breast Care (Basel, Switzerland)|May 12, 2015
Familial breast cancer - targeted therapy in secondary and tertiary preventionKarin Kast, Kerstin Rhiem
Current Oncology (Toronto, Ont.)|May 15, 2023
Assessing Psychological Morbidity in Cancer-Unaffected <i>BRCA1/2</i> Pathogenic Variant Carriers: A Systematic ReviewAnna Isselhard, Zoë Lautz, Kerstin Rhiem, et al.
Qualitative Research in Medicine & Healthcare|July 13, 2023
The ticking time-bomb. Health literacy in the context of genetic risk prediction in familial breast-ovarian cancer; A qualitative studyMariya Lorke, Laura Harzheim, Kerstin Rhiem, et al.
Deutsches Arzteblatt International|June 4, 2011
Hereditary breast and ovarian cancer: new genes, new treatments, new conceptsAlfons Meindl, Nina Ditsch, Karin Kast, et al.
Molecular and Clinical Oncology|August 11, 2022
Long-term survival of a <i>BRCA2</i> mutation carrier following second ovarian cancer relapse using PARPi therapy: A case reportKathrin Bredow, Britta Blümcke, Stephanie Schneider, et al.
Anticancer Research|October 15, 2010
Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomasKerstin Rhiem, Unda Todt, Barbara Wappenschmidt, et al.
Breast Care (Basel, Switzerland)|June 15, 2017
Germline Mutations in Triple-Negative Breast CancerEric Hahnen, Jan Hauke, Christoph Engel, et al.
Archives of Gynecology and Obstetrics|September 19, 2013
Supplemental screening ultrasound increases cancer detection yield in BRCA1 and BRCA2 mutation carriersKristin Bosse, Monika Graeser, Axel Goßmann, et al.
International Journal of Environmental Research and Public Health|March 25, 2022
"You Always Have It in the Back of Your Mind"-Feelings, Coping, and Support Needs of Women with Pathogenic Variants in Moderate-Risk Genes for Hereditary Breast Cancer Attending Genetic Counseling in Germany: A Qualitative Interview StudyClaudia Stracke, Clarissa Lemmen, Kerstin Rhiem, et al.
Pageof 17